Search

everythinglearnresearchcommunity

for

Search:↓

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Marine-derived ingredients show potential for hair health but need more human trials to confirm effectiveness.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Balding and low testosterone increase risk of urinary stones.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Vitamin D and calcium are essential for normal hair growth.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

A man got brown patches on his skin (melasma) after taking finasteride, a hair loss treatment.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Cynomorium songaricum has many health benefits and could help with hair regrowth.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.